Franklin Resources Inc. boosted its holdings in Chemed Co. (NYSE:CHE - Free Report) by 18.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 10,436 shares of the company's stock after buying an additional 1,636 shares during the period. Franklin Resources Inc. owned approximately 0.07% of Chemed worth $5,529,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. HighTower Advisors LLC lifted its holdings in shares of Chemed by 78.0% during the 3rd quarter. HighTower Advisors LLC now owns 3,730 shares of the company's stock valued at $2,246,000 after acquiring an additional 1,634 shares in the last quarter. Quantinno Capital Management LP grew its stake in shares of Chemed by 29.9% in the third quarter. Quantinno Capital Management LP now owns 1,587 shares of the company's stock valued at $954,000 after buying an additional 365 shares in the last quarter. National Bank of Canada FI acquired a new position in Chemed during the 3rd quarter worth approximately $1,496,000. MML Investors Services LLC boosted its holdings in Chemed by 3.9% in the 3rd quarter. MML Investors Services LLC now owns 1,457 shares of the company's stock worth $876,000 after acquiring an additional 55 shares during the period. Finally, Geode Capital Management LLC grew its position in Chemed by 4.9% in the third quarter. Geode Capital Management LLC now owns 335,443 shares of the company's stock valued at $201,820,000 after acquiring an additional 15,791 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.
Chemed Stock Down 1.6 %
Shares of Chemed stock traded down $9.42 on Tuesday, hitting $591.27. 61,888 shares of the company's stock traded hands, compared to its average volume of 97,134. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $625.09. The stock has a market cap of $8.64 billion, a P/E ratio of 29.88, a PEG ratio of 2.15 and a beta of 0.49. The firm's 50-day moving average is $583.92 and its 200 day moving average is $567.73.
Chemed Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. The ex-dividend date was Monday, February 24th. Chemed's payout ratio is currently 10.05%.
Insider Activity
In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the sale, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. The trade was a 1.91 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 3.32% of the company's stock.
Analyst Ratings Changes
Several brokerages have recently weighed in on CHE. Royal Bank of Canada upped their target price on shares of Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a research note on Friday, March 14th. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th.
Check Out Our Latest Report on CHE
Chemed Company Profile
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Articles
Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
